The effect of tolvaptan on renal function during intensive treatment in patients with congestive heart failure

Trial Profile

The effect of tolvaptan on renal function during intensive treatment in patients with congestive heart failure

Completed
Phase of Trial: Phase II

Latest Information Update: 12 May 2016

At a glance

  • Drugs Tolvaptan (Primary) ; Canrenoic acid; Carperitide; Furosemide
  • Indications Acute heart failure; Chronic heart failure; Renal failure
  • Focus Adverse reactions
  • Most Recent Events

    • 12 May 2016 Last checked against University Hospital Medical Information Network - Japan record.
    • 04 Nov 2014 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 13 Jun 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top